Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
(2016) A phase I new approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent/refractory high-risk neuroblastoma, Pediatr
they determine whether weight loss translates into preserved muscle and better long-term health
Understanding when medication adjustments may be warranted requires clear communication between patients and their healthcare teams
The importance of baseline assessment Before starting any bone health protocol, a baseline DEXA scan provides essential data
Limitations of an open-label study may be related to a bias in evaluation of the outcomes, efficacy and/or safety, and analysis was not tested against a placebo-controlled comparison group
US$ 29.38
US$ 27.57
US$ 26.55
US$ 25.39
US$ 28.95
US$ 26.75
